JP2006524243A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524243A5
JP2006524243A5 JP2006509825A JP2006509825A JP2006524243A5 JP 2006524243 A5 JP2006524243 A5 JP 2006524243A5 JP 2006509825 A JP2006509825 A JP 2006509825A JP 2006509825 A JP2006509825 A JP 2006509825A JP 2006524243 A5 JP2006524243 A5 JP 2006524243A5
Authority
JP
Japan
Prior art keywords
use according
animal
syndrome
cognitive
training
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509825A
Other languages
English (en)
Japanese (ja)
Other versions
JP4833834B2 (ja
JP2006524243A (ja
Filing date
Publication date
Priority claimed from US10/410,508 external-priority patent/US20040224316A1/en
Application filed filed Critical
Publication of JP2006524243A publication Critical patent/JP2006524243A/ja
Publication of JP2006524243A5 publication Critical patent/JP2006524243A5/ja
Application granted granted Critical
Publication of JP4833834B2 publication Critical patent/JP4833834B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006509825A 2003-04-08 2004-04-08 増強認知訓練 Expired - Fee Related JP4833834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/410,508 2003-04-08
US10/410,508 US20040224316A1 (en) 2000-08-10 2003-04-08 Augmented cognitive training
PCT/US2004/010876 WO2004091609A2 (en) 2001-08-10 2004-04-08 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

Publications (3)

Publication Number Publication Date
JP2006524243A JP2006524243A (ja) 2006-10-26
JP2006524243A5 true JP2006524243A5 (https=) 2011-03-24
JP4833834B2 JP4833834B2 (ja) 2011-12-07

Family

ID=37416211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509825A Expired - Fee Related JP4833834B2 (ja) 2003-04-08 2004-04-08 増強認知訓練

Country Status (7)

Country Link
US (2) US20040224316A1 (https=)
EP (4) EP2340831B1 (https=)
JP (1) JP4833834B2 (https=)
AT (1) ATE556707T1 (https=)
CA (1) CA2521839C (https=)
ES (3) ES2403333T3 (https=)
WO (1) WO2004091609A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868015B2 (en) 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
ATE526020T1 (de) * 2000-08-10 2011-10-15 Cold Spring Harbor Lab Gesteigertes kognitives training
US9931318B2 (en) 2003-04-08 2018-04-03 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
US8153646B2 (en) 2000-08-10 2012-04-10 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
US8975216B2 (en) * 2006-03-30 2015-03-10 Pacific Biosciences Of California Articles having localized molecules disposed thereon and methods of producing same
BRPI0711816A2 (pt) * 2006-05-19 2011-12-13 Helicon Therapeutics Inc inibidores fosfodiesterase 4 para rehabilitação motora e cognitiva
CA2680414A1 (en) * 2007-03-12 2008-09-18 Biolipox Ab Piperidinones useful in the treatment of inflammation
GB0722769D0 (en) * 2007-11-21 2008-01-02 Biolipox Ab New compounds
JP2010527243A (ja) * 2007-05-15 2010-08-12 ヘリコン セラピューティクス，インコーポレイテッド 低分子干渉ＲＮＡ（ｓｉＲＮＡ）を用いた記憶形成に関わる遺伝子の同定方法
KR20100029079A (ko) * 2007-05-15 2010-03-15 헬리콘 테라퓨틱스 인코퍼레이티드 Ｇｐｒ12의 저해로 인지 질환을 치료하는 방법
JP5049713B2 (ja) * 2007-09-14 2012-10-17 株式会社コナミデジタルエンタテインメント ゲームシステム並びにこれを構成するゲーム装置及び課題報知装置
JP5789511B2 (ja) * 2008-07-18 2015-10-07 ダート ニューロサイエンス （ケイマン） エルティーディー 記憶剤の評価のための方法およびシステム
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
US20150050626A1 (en) * 2013-03-15 2015-02-19 Dart Neuroscience, Llc Systems, Methods, and Software for Improving Cognitive and Motor Abilities
EP3125900A1 (en) * 2014-03-28 2017-02-08 Algiax Pharmaceuticals GmbH Treatment of cognitive disorders
JP2017141222A (ja) * 2016-02-09 2017-08-17 国立大学法人帯広畜産大学 パーキンソン病に併発した認知障害の治療剤及びそのスクリーニング方法
CN116963773A (zh) 2021-01-21 2023-10-27 浙江养生堂天然药物研究所有限公司 治疗肿瘤的组合物及方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5479508A (en) * 1991-05-22 1995-12-26 Zenith Electronics Corp. Method of operating a pay per view television system
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
HU225869B1 (en) 1992-04-02 2007-11-28 Smithkline Beecham Corp Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
US5681735A (en) 1992-04-10 1997-10-28 Fox Chase Cancer Center Transcription control element for increasing gene expression in myoblasts
KR970705562A (ko) * 1994-08-29 1997-10-09 오노다 마사요시 신규한 나프티리딘 유도체 및 이의 의약 조성물(Novel naphthyridine derivatives and medicinal composition thereof)
US5619249A (en) * 1994-09-14 1997-04-08 Time Warner Entertainment Company, L.P. Telecasting service for providing video programs on demand with an interactive interface for facilitating viewer selection of video programs
US5929223A (en) * 1994-10-07 1999-07-27 Cold Spring Harbor Laboratory Cloning and characterizing of genes associated with long-term memory
CA2202087C (en) 1994-10-07 2011-12-06 Timothy P. Tully Cloning and characterizing of genes associated with long-term memory
US5652749A (en) * 1995-02-03 1997-07-29 International Business Machines Corporation Apparatus and method for segmentation and time synchronization of the transmission of a multiple program multimedia data stream
US5793410A (en) * 1995-05-26 1998-08-11 Hyundai Electronics America Video pedestal network
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
PT936923E (pt) * 1996-11-15 2004-04-30 Kennedy Inst Of Rheumatology Supressao de tnfalfa e il-12 em terapia
TR199901653T2 (xx) * 1997-01-15 1999-10-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Fitalazinonlar.
WO2000014083A1 (en) 1998-09-09 2000-03-16 Inflazyme Pharmaceuticals Ltd. SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
AU764005B2 (en) 1999-02-25 2003-08-07 Merck Frosst Canada & Co. PDE IV inhibiting compounds, compositions and methods of treatment
US6436965B1 (en) 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
ATE526020T1 (de) * 2000-08-10 2011-10-15 Cold Spring Harbor Lab Gesteigertes kognitives training
DK1540335T3 (da) * 2002-08-19 2010-07-26 Helicon Therapeutics Inc Screeningsfremgangsmåder til kognitive forstækere

Similar Documents

Publication Publication Date Title
JP2006524243A5 (https=)
Kemeny et al. Emotions, the neuroendocrine and immune systems, and health
JP2019031502A5 (https=)
WO2004026246A3 (en) Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors
EA200700427A1 (ru) Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
WO2017178807A1 (en) Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia
WO2004030524A3 (en) Treatment of autism and similar disorders
Guercio et al. Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research
DE60326548D1 (de) Verfahren zur verhütung oder behandlung von herzarrhythmie
DE602005025347D1 (de) Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
JP5517925B2 (ja) パーキンソン病治療薬
JP5517926B2 (ja) パーキンソン病治療薬
Badran et al. Recovery Mimicking “Ideal” CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents
Tellez et al. Autoradiographic study of serotonin transporter during memory formation
ATE429216T1 (de) Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson
Ferreira et al. Health care reform or more affordable health care?
Li et al. Nicotinic acetylcholine signaling is required for motor learning but not for rehabilitation from spinal cord injury
RU2005114505A (ru) Применение (2-имидазолин-2-иламино) хиноксалинов для лечения деменции и болезни паркинсона
JPWO2019157273A5 (https=)
ATE432070T1 (de) Herabgesetzte dosis von tolterodin zur behandlung von harnwegserkrankungen
Doe et al. Behavioral despair during a water maze learning task in mice
JP2012090626A (ja) 疲労の評価方法
EA200801278A1 (ru) Способ коррекции функциональных расстройств организма человека
JP2007130424A (ja) 電気・磁気刺激方法、電気・磁気刺激装置及び電気・磁気刺激評価方法
Orihuela-Flores et al. Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: A case report